Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers — Dallas, Texas

Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes.

Sponsors: Gemin X.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers?

Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers conducted?

Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers has 1 clinical trials on record. Their work covers Myelodysplastic Syndromes.

Is Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers accredited by Crixeo Clinical Trials?

Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.